Aduro Presents Positive Results on BION-1301 for Treating Multiple Myeloma
Aduro Biotech recently presented positive preclinical data showing that…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
2 Common Additions to Multiple Myeloma Therapy Don’t Offer Added Benefit, Study Says
The results of a new clinical trial suggest that…
Bluebird’s CAR T-cell Therapy Shows Promise in Advanced Multiple Myeloma Patients
Patients with advanced multiple myeloma may benefit from bluebird…
Blood Purification Technique Could Offer Therapeutic Benefits for Multiple Myeloma
A technique called extracorporeal blood purification (EBP) could be used to remove certain molecules from the blood and potentially treat different conditions including multiple myeloma and kidney complications associated with it.
Extra Weight in Precancerous Stages Increases Risk of Multiple Myeloma, Study Finds
Patients in a precancerous stage of multiple myeloma would…
Ninlaro Granted Conditional Approval by European Commission to Treat Multiple Myeloma
The European Commission has granted conditional marketing authorization to…
